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ABSTRACT: Organic response to infection is characterized by a systemic reaction known as acute phase response (APR). In 
order to know the effect of the administration of Escherichia coli lipopolysaccharide (LPS) on physiological, hematological 
and biochemical variables, 10 sheep weighing 45 ± 5 kg were divided in two groups: Experimental group treated with 3 doses 
of 1 μg.kg-1 LPS and control group treated with saline solution (SS) at the same frequency as experimental group. Body tem-
perature (BT°), heart rate (HR) and respiratory rate (RR) were monitored. Blood samples for hemogram and enzyme activity 
for aspartate amino transferase (AST) and gamma glutamyl transferase (GGT) were collected between 1 and 24 h post-LPS. 
LPS-treated sheep presented mean values of BT (41.2 ± 0.4°C), HR (132 ± 12.3 beats/min) and RR (107.2 ± 25 cycles/min) 
higher than those observed in control sheep (39.8 ± 0.2°C, 88.8 ± 8.7 beats/min and 53.6 ± 17.1 cycles/min respectively).
Between 4 and 8 hours post-injection (hpi) of LPS the leukocyte count was associated with lymphopenia, followed by leu-
kocytosis at 24 hours. No changes were observed in the activity of AST and GGT enzymes. The results characterize APR 
induced by LPS in sheep, representing a useful model to study cardiovascular, hematological and biochemical responses to 
infection.
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ALTERAÇÕES CLÍNICAS E HEMATOLÓGICAS INDUZIDAS PELA ADMINISTRAÇÃO DE 
LIPOPOLISSCARÍDEO DE Escherichia coli EM OVELHAS
RESUMO: A resposta orgânica à infecção é caracterizada por uma reação sistêmica conhecida como resposta de fase aguda 
(RFA). Para conhecer o efeito da administração de lipopolissacárideo (LPS) de Escherichia coli sobre as variáveis fisioló-
gicas, hematológicas e bioquímicas, 10 carneiros pesando 45 ± 5 kg foram divididos em dois grupos: o grupo experimental 
tratado com três doses de 1 μg.kg -1 de LPS e grupo controle tratado com solução salina (SS) na mesma frequência que o 
grupo experimental. Temperatura corporal (T°C), frequência cardíaca (FC) e frequência respiratória (FR) foram monitoradas. 
As amostras de sangue foram tomadas para hemograma e atividade da enzima aspartato aminotransferase (AST) e gama-
-glutamiltransferase (GGT) entre uma e 24 h pós-LPS. Ovelhas tratadas com LPS apresentaram valores médios de T°C (41,2 
± 0,4°C), FC (132 ± 12,3 batimentos/min) e FR (107,2 ± 25 ciclos/min) acima dos observados em ovelhas do tratamento 
controle (39,8 ± 0,2°C, 88,8 ± 8,7 batimentos/min e 53,6 ± 17,1 ciclos/min, respectivamente). Entre 4 e 8 horas após a injeção 
de LPS, a contagem de leucocitos foi asociado com linfopenia, seguida de leucocitose as 24 horas. Nenhuma mudança na 
atividade das enzimas AST e GGT foi observada. Os resultados caracterizam uma resposta de fase aguda induzida por LPS 
em ovelhas, o que representa um modelo útil para estudar os sistemas cardiovascular, hematológico e bioquímico em resposta 
à infecção.
PALAVRAS CHAVE: Endotoxina. Escherichia coli. Febre. Hematologia. Inflamação. 
ALTERACIONES CLÍNICAS Y HEMATOLÓGICAS INDUCIDAS POR LA ADMINISTRACIÓN DE 
LIPOPOLISCÁRIDO DE Escherichia coli EN OVEJAS
RESUMEN: La respuesta orgánica a la infección se caracteriza por una reacción sistémica conocida como respuesta de fase 
aguda (RFA). Para conocer el efecto de la administración de lipopolisacárido (LPS) de Escherichia coli sobre las variables fi-
siológicas, hematológicas y bioquímicas, 10 ovejas con un peso de 45 ± 5 kg se dividieron en dos grupos: grupo experimental 
tratado con 3 dosis de 1 μg.kg-1de LPS y grupo control tratado con solución salina (SS) en la misma frecuencia que el grupo 
experimental. Temperatura corporal (T°C), frecuencia cardíaca (FC) y frecuencia respiratoria (FR) fueron monitoreadas. Se 
tomaron muestras de sangre para hemograma y actividad enzimática para el aspartato amino transferasa (AST) y gamma 
glutamil transferasa (GGT) entre 1 y 24 h post-LPS. Las ovejas tratadas con LPS presentaron valores medios de T°C (41.2 ± 
0.4°C), FC (132 ± 12.3 latidos / min) y FR (107.2 ± 25 ciclos/min) por encima de los observados en ovinos controles (39.8 
± 0.2°C, 88.8 ± 8.7 latidos/min y 53.6 ± 17.1 ciclos/min respectivamente). Entre las 4 y 8 horas después de la inyección de 
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INTRODUCTION
Bacterial infections are one of the main factors that 
reduce performance of livestock production systems, increa-
sing morbidity and mortality of animals (DUFF; GALYEAN, 
2007). One of the main effects of these infections is sepsis, 
which arises as a complex inflammatory deregulation, when 
the body’s immune response to a bacterial infection is unable 
to control it successfully (BURAS; HOLZMANN; SITKO-
VSKY, 2005). Physiological response to infection consists 
of local inflammation and the initiation of a series of events 
leading to a systemic response called acute phase response 
(APR). The multiplicity of effects that occur during APR 
include both metabolic and physiological reactions (PEAT-
MAN et al., 2007), such as fever and leukopenia followed 
by leukocytosis (GRYDLEY; MILLER; PECAUT, 2007). 
These reactions occur as well as changes in the concentration 
of a group of plasma proteins known as acute phase proteins 
(APP), which are synthesized in the liver and are related to 
a wide range of activities related to immunity (PEATMAN 
et al., 2007). The APR starts at a local inflammatory site and 
involves basically three key processes: (1) hemodynamic 
changes, (2) altered vascular permeability, and (3) changes in 
leukocyte count. These processes are initiated by the activa-
tion of cells such as monocytes, mast cells and basophils that 
circulate in the bloodstream. As a result, several soluble, va-
soactive and chemotactic substances that affect vascular per-
meability and stimulate pain receptors are released (BLAT-
TEIS, 2006). There is evidence that bacterial endotoxins, 
such as lipopolysaccharides (LPSs), are an important factor 
in the pathophysiology of septic shock generated by Gram 
negative microorganisms (RAMACHANDRAN, 2014).
A LPS is a glycolipid molecule that is attached to 
the outer membrane of Gram-negative bacteria, and plays 
an important role in the activation of the immune system to 
constitute the most important surface antigen of this type of 
bacteria.It has a potent endotoxic action and is responsible 
for septic shock induced by these of pathogens (HURTA-
DO; IREGUI, 2010). Escherichia coli LPS has been widely 
used as an alternative model for infections, because of its 
potent pyretic and immuno-stimulatory capacity in animals 
(MORGAN et al., 2008).In addition, it has been used to cre-
ate reproducible systems for the study of the pathogenesis of 
sepsis (BURAS; HOLZMANN; SITKOVSKY, 2005), since 
this endotoxin generates characteristic clinical signs of this 
phenomenon such as fever, tachycardia and leukocyte acti-
vation (PLESSERS et al., 2015).
The complexity of sepsis makes its clinical study 
difficult; therefore, animal models have been developed as 
a way to create reproducible systems to study their pathoge-
nesis (BURAS; HOLZMANN; SITKOVSKY, 2005). Within 
the literature, little data that describe the magnitude and con-
nection between inflammatory parameters after exposure to 
low doses of Escherichia coli LPS in sheep, this is associa-
ted with the great variability of the reference values for the 
haematology and clinical biochemistry of these animals in 
different regions of the world (BRAUN; TRUMEL; BÉZIL-
LE, 2010).
The main objective of the present study was to in-
vestigate the clinical and haematological response of sheep 
subjected to intravenous exposure of low doses of LPS,to de-
velop a reproducible model that is useful to study the effect 
of infection and inflammation on the pharmacokinetic cha-
racteristics of veterinary drugs.
MATERIALS AND METHODS
Location and year of study. This study was car-
ried out during the winter season of the year 2015 in the De-
partment of Clinical Sciences of the Faculty of Veterinary 
Sciences of the University of Concepción, Chillán Campus 
in Chile (36° 36’S, 72° 7’O). 
Experimental animals. A group of 10 clinically 
healthy Suffolk Down sheep of 12 months of age and 40-50 
kg body weight (bw) were selected for the study. Sheep were 
housed in collective pens, which met individual requirements 
of space, dry bedding, ventilation and free access to water. 
Sheep were fed daily with alfalfa hay, supplemented with 
grain oats (300 g/sheep).All procedures were approved by 
the Bioethics Committee of the Faculty of Veterinary Scien-
ces, University of Concepción, Chile. 
Reagents. Purified LPS from Escherichia coli 
O128-B12 was purchased from Sigma-Aldrich (Santiago, 
Chile). An endotoxin stock solution was prepared by diluting 
2 mg of LPS in 10 mL of sterile pyrogen-free saline solution 
(SS). Then, 1 mL of the solution was diluted to a final con-
centration of 20 μg mL-1, used to apply a dose of 1 mL 20 
kg-1 bw.
Experimental design. A 2x2 factorial design was 
used, which consisted of the use of animal pairs (blocks) 
similar in body weight and corresponding to the same sex. 
Animals were divided into two groups. Experimental group 
was treated with three intravenous doses of 1 μg kg-1 bw of 
LPS through the right jugular vein at 0, 8 and 24 hours (h) 
after initiating the study to induce an APR.Control group was 
treated with the same volume of SS at intervals similar to 
those of LPS group.
Record of Physiological Constants. During the 
test period (0 to 36 hours), heart rate (beats/min), respiratory 
rate (cycles/min) and rectal temperature (°C) were recorded 
every 15 minutes using a multi-parameter monitor (Mek´s, 
MP 800, Kangwon-do, New Global Leader, Korea). An in-
crease of 0.8 °C above the basal rectal temperature of the 
sheep was considered as an indicator of fever. In addition, 
the ambient temperature was measured by a maximum and 
minimum temperature thermometer.
Processing of blood samples. Blood samples (3 
mL) were obtained by jugular puncture vein before, during 
1, 4, 8, 12 and 24 h and after the first administration of LPS 
or SS. Blood was collected in a tube with ethylene diamine 
tetraacetic acid (EDTA) for the blood count analysis and in a 
tube without anticoagulant for the biochemical analysis. Ani-
LPS, el recuento de leucocitos se asoció a linfopenia, seguida de leucocitosis a las 24 horas. No se observaron cambios en la 
actividad de las enzimas AST y GGT. Los resultados caracterizan una respuesta de fase aguda inducida por LPS en ovinos, re-
presentando un modelo útil para estudiar los sistemas cardiovascular, hematológico y bioquímico en respuesta a la infección.
PALABRAS CLAVE: Endotoxina. Escherichia coli. Fiebre. Hematología. Inflamación.
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mals were visually inspected for any adverse effects during 
each sampling time over a 36 h period.
Analysis of blood samples. Globular volume (%) 
of blood was determined by the microhematocrit method 
(FELDMAN et al., 2000). Total leukocyte count was de-
termined using the Hayem B technique (FELDMAN et al., 
2000). In addition, the differential count of leukocytes and 
platelet count were determined by means of optical micros-
copy using Romanowsky staining. Activity of the aspartate 
amino transferase (AST) and gamma glutamyltranspeptidase 
(GGT) enzymes was determined using a microplate in which 
the commercial reagent from the Wiener® laboratory (Bue-
nos Aires, Argentina) corresponding to the evaluated analyte 
was added to each well. The concentrations of each analyte 
are proportional to the enzymatic-colorimetric reaction, 
which were measured at a wavelength of 540 nm by spec-
trophotometry (Multiskan Go, Thermo Scientific®, Vantaa, 
Finland).
Statistical analysis. Results were expressed as me-
ans and standard error of the mean (SEM), and were compa-
red by analysis of variance (ANOVA) for repeated measu-
rements associated with a Tukey multiple comparison test. 
A value of P ≤ 0.05 was considered to establish statistically 
significant differences.
RESULTS AND DISCUSSION
Inoculation of animals with pure or mixed bacterial 
agents has been a common tool for the study of the mecha-
nisms of animal sepsis, and is used to develop a reproducible 
and rapid disease model compared to human sepsis models 
(BURAS; HOLZMANN; SITKOVSKY, 2005). The utility 
of LPS as an exposure model is that it is relatively cheap and 
easy to reproduce, since it is not always possible to develop 
reliable disease models to carry out pharmacokinetic studies 
in food-producing animals (POST et al., 2003). The model 
used in the present study allowed the generation of an APR 
with three repeated doses of LPS to simulate an inflamma-
tory response to infection. This was done in order to charac-
terize the changes in the physiological, hematological and 
biochemical variables in healthy sheep. 
Mean body temperatures (BT°s) observed in both 
study groups of sheep are shown in Figure 1a. Experimental 
group and control group had a baseline BT° of 39.6 ± 0.12 
and 39.7 ± 0.1 °C, respectively. In control group after ad-
ministration of saline solution, BT° remained within normal 
ranges throughout the study period. In contrast the sheep of 
experimental group presented a febrile response as the main 
clinical sign of infection. 
The increase in temperature started 1 h after LPS 
administration and was maintained until 5.5 hpi, reaching a 
maximal difference of 1.7 °C at 3.5 h after the first LPS injec-
tion, and 1.3 °C at 1.25 h after the second injection. These di-
fferences were significant with respect to baseline (P <0.05) 
and values observed in the control group (P <0.05). The re-
turn to baseline BT° occurred at 6 h after each LPS applica-
tion. Similar results were obtained in sheep by Jones et al. 
(2000). Studies carried out on rabbits by Marca et al. (2009) 
and Huang et al. (2008) describe similar febrile responses.
The initial increase in temperature is due to the par-
ticipation of pyrogenic cytokines derived from reticuloen-
dothelial cells and phagocytes. These cytokines (IL-1, IL-2, 
IL-6, interferons and tumor necrosis factor) are transcribed, 
translated and subsequently reach the central nervous system 
(CNS) by crossing areas with leakage in the blood-brain bar-
rier through the organum vasculosum terminalis, where they 
act on certain structures to trigger fever, either by their direct 
action on the receptors or by the biosynthesis of other cytoki-
nes (DALAL; ZHUKOVSKY, 2006). The delay in reaching 
the temperature peaks is explained by the need for synthesis 
and/or presence of prostaglandin E2 (PGE2) in the ventro-
medial nucleus of the anterior hypothalamic pre-optic area 
(thermoregulatory center of the organism), whose synthesis 
from the arachidonic acid is selectively regulated by pyroge-
nic cytokines (BLATTEIS, 2003; DALAL; ZHUKOVSKY, 
2006). The shorter time to reach the second temperature rise 
is because cytokines are already present in the area, and the-
refore their synthesis and transfer to the hypothalamus is not 
necessary. 
The return of BT° to baseline values occurred at 6 
h after each LPS application. The rapid recovery of the basal 
temperature could be explained by a dose-dependent effect of 
LPS, since at low doses the fever presents a monophasic tem-
perature pattern with a rapid recovery after the temperature 
peak is reached, in contrast to what happens with moderate 
to high doses of LPS, where biphasic or triphasic patterns 
have been observed with a slower recovery of basal tempera-
ture (RUDAYA et al., 2005). This has been demonstrated by 
Jacobsen, Toelboell and Andersen (2005), who administered 
increasing doses of LPS of 10-100-1000 μg kg-1 to cows, and 
found that these responded with a mono, bi and three-phase 
BT° pattern respectively, correlating the doses with basal 
BT° recovery. These BT° patterns are explained by different 
“waves” of PGE2 synthesis (BLATTEIS et al., 2005).
The mean heart rate (HR) values corresponding to 
both groups are presented in Figure 1b. In the control group, 
HR remained within normal physiological ranges throughout 
the study, presenting no significant differences (P> 0.05) with 
respect to the baseline value (92 ± 3.2 beats per minute). Sig-
nificant increases (P <0.05) in HR were observed in the ex-
perimental group compared to the baseline (90.8 ± 3.18 beats 
per minute), at 7 - 9.5 - 24.5 - 24.75 h after initiation of the 
study. The statistical comparison of the averages observed 
between the two groups showed that there were significant 
differences in heart rate during a large part of the study, with 
the greatest difference occurring 1 h after injection of the se-
cond dose of LPS (P <0.05). 
The sustained increase in heart rate is correlated 
with the first phase of sepsis, known as the hyper dynamic 
phase (BURAS; HOLZMANN; SITKOVSKY, 2005) which 
is characterized by a decrease in systemic vascular resistance 
(SVR) and an increase in cardiac output mediated initially 
by the release of bradykinin and histamine (BERMEJO; DU-
ARTE, 2003). Tissue perfusion decreases and therefore oxy-
gen consumption also decreases. Moreover, the activation of 
white blood cells releases vasoactive agents so that in some 
areas of the vascular bed there is dilatation, and in others 
constriction (BERMEJO; DUARTE, 2003). The tachycardia 
present in these animals was similar to that described by Ya-
tes et al. (2011), who found increases in heart rate in sheep 
treated with 1.5 μg kg-1 of LPS. Plessers et al. (2015) had 
similar results in calves treated with doses of 0.5 μg kg-1 LPS. 
50
Arq. Ciênc. Vet. Zool. UNIPAR, Umuarama, v. 21, n. 2, p. 47-53, abr./jun. 2018
Clinical and hematological changes... RIQUELME et al.
ISSN 1982-1131
Figure 1. Mean (± SE) of rectal temperature (a), heart rate 
(b) and respiratory rate (c) in control group sheep and those 
treated with E. coli LPS (n = 5).
*Significant differences (P <0.05) with respect to baseline. Different 
lowercase letters vertically (a, b) indicate significant differences be-
tween groups (P <0.05).
Figure 1c shows the averages of respiratory rate 
(RR) for both experimental groups. In the control group, RR 
remained within normal physiological ranges throughout the 
study, with no significant differences (P> 0.05) with respect 
to baseline (56 ± 3.7 cycles per minute). In the experimen-
tal group, there were statistically significant differences (P 
<0.05) with respect to baseline (53.2 ± 3.7 cycles/min), at 
25.5 and 25.75 hpi. Respiratory rate showed a similar ten-
dency to heart rate and was higher in LPS-treated animals. 
Comparison of mean values showed that there were signifi-
cant differences in respiratory rate between the two groups 
over all part of recording. Some treated animals had mild 
coughing periods. 
The increase in RR represents the response of the 
organism to an increase in BT° as a way to increase heat dis-
sipation through panting and tachypnea. Meanwhile periods 
of coughing should be due to injury and/or irritation of the 
respiratory tree syndrome caused by the endotoxin. At 8 h 
after the first LPS injection the RR was normalized, which 
coincides with the decrease in BT°. The anti-inflammatory 
action of activated protein C (APC) would aid in the cessation 
of respiratory symptomatology (BURAS; HOLZMANN; SI-
TKOVSKY, 2005). APC is an important route in the regu-
lation of coagulation and inflammation during septicemia, 
as it has anti-inflammatory action and also improves tissue 
perfusion (BURAS; HOLZMANN; SITKOVSKY, 2005). 
Intravenous LPS administration models have been made in 
rats to determine the effect of APC on lung injury. These stu-
dies demonstrated that exogenous APC reduces LPS-induced 
lung injury through inhibition of cytokine production and 
activation of leukocytes (BURAS; HOLZMANN; SITKO-
VSKY, 2005).
Average total leukocyte counts per group are pre-
sented in Figure 2a. The control group had a baseline total 
white blood cell count of 9760 ± 1116.7 μL-1 cells, remaining 
at similar values throughout the sampling period. Meanwhi-
le, the experimental group had a baseline count of 9280 ± 
723 leukocytes μL-1, with no difference between baseline va-
lues in both groups. However, at 4hpi, a decrease in white 
blood cell count was observed in LPS’s treated sheep, resul-
ting in a slight leukopenia. Notwithstanding, this difference 
was not statistically significant with respect to the baseline 
value, but it was statistically significant with respect to the 
values of control group (P <0.05). This early cellular respon-
se is mainly attributed to the infiltration and storage of white 
line cells in organs such as the liver and spleen, generating in 
the latter the splenomegaly characteristic of Gram negative 
sepsis (GRIDLEY et al., 2007). 
In the present study, the initial leukopenia is due to 
a decrease in the lymphocyte count whose values were lo-
wer than 50% of the basal value, as observed in Figure 2b. 
Similar results were found by Peñailillo et al. (2016) in ra-
bbits treated with LPS, where a decrease in leukocytes was 
observed at 4 hpi and then showed an increase between 12 
and 24 hpi. In the LPS treated group of sheep, the initial leu-
kopenia was followed by an increase in leukocytes at 8 and 
24 h, with statistically significant differences to the control 
group (P <0.05) at 8 and 12 hpi. These results are consistent 
with those reported by Rose and Semrad (1992), Bieniek et 
al. (1998), Bannerman et al. (2003) and Jacobsen, Toelboell 
and Andersen (2005) in cattle. Peñailillo et al. (2016) obser-
ved an increase in the neutrophil counts from 12 h post treat-
ment in rabbits. In the literature, it has been speculated that 
this phenomenon could be attributed to a synergistic effect 
between LPS and the release of corticosteroids in the body. 
The latter condition leads the animal to produce a higher le-
vel of chemo attractant cytokines such as interleukin 1 (IL-1) 
and necrosis factor alpha (FNTa), which stimulate the release 
of immature cells from the bone marrow into the circulation 
(ALTENBURG et al., 2002).
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Figure 2.  Average total white blood cell (WBC. / µL-1) (a), 
lymphocyte count (Nº of lymphocyte µL-1) (b), neutrophil 
count (Nº of neutrophils µL-1) (c) in control sheep and those 
treated with E. coli LPS (n = 5).  
⃰P<0.05 vs baseline. Different lowercase letters vertically (a, b) indi-
cate significant differences between groups (P <0.05).
Neutrophil count averages are presented in Figure 
2c. The control group had a baseline count of 2763.4 ± 538.8 
μL-1 neutrophils, remaining at similar averages throughout 
the sampling period. The experimental group had a baseline 
count of 3526.8 ± 844.5 μL-1 neutrophils, with no statisti-
cally significant difference (P> 0.05) found between baseline 
values in both groups.
In sheep treated with LPS, a decrease in neutrophil 
counts was observed after 1hpi, resulting in mild neutrope-
nia. This difference was statistically significant with respect 
to baseline and control group (P <0.05). Then, from 4 hpi an 
increase was observed in the number of neutrophils arriving 
at their peak at 24 hpi, with statistically significant differen-
ces with respect to the basal value and to the control group 
(P <0.05).
Table 1 shows the averages of the globular volume 
(GV%), hemoglobin concentration, differential monocyte 
count, platelet count, enzymatic activity of GGT and AST 
obtained in both groups. Statistical analysis did not show 
significant variations in mean globular volume (GV), hemo-
globin, and platelet count in LPS-treated sheep. These results 
are similar to those reported by Bieniek et al. (1998) in cal-
ves, and by Peñailillo et al. (2016) in rabbits treated with 
LPS. However, Yates et al. (2011) describe an increase in GV 
in sheep treated with LPS, an effect attributed to the splenic 
contraction that results in the release of erythrocytes into the 
bloodstream.
Activity of the AST and GGT enzymes did not show 
significant variations with respect to their baseline value after 
administration of LPS. These results agree with those obtai-
ned by Ramírez (2011) in sheep treated with similar doses of 
LPS. Therefore, it is inferred that the dose of LPS was not 
sufficient to cause alterations in liver functionality. However, 
significant increases have been observed in the mean values 
of these enzymes in rabbits treated with high doses (100 μg 
kg-1) of LPS (ELMAS et al., 2008).
Table 1. Mean ± SEM of globular volume, hemoglobin, platelet count, monocyte count, AST and GGT enzyme activity in 
control group sheep and those treated with Escherichia coli LPS.
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It is known that LPS is attached to the outer membra-
ne of Gram-negative bacteria (HURTADO; IREGUI, 2010). 
Within these E. coli LPS is one of the most widely used en-
dotoxins as an alternative model to infections (MORGAN et 
al., 2008), although this model is not a generic substitute for 
bacterial infections and acute inflammatory responses (POST 
et al.,  2003), it is easy to use and relatively similar to these 
(ELMAS et al., 2008).
There is evidence indicating that the pharmacoki-
netics of drugs vary during the occurrence of a pathological 
state or an infection that involves an inflammatory compo-
nent, therefore, the ability to handle these drugs is dimini-
shed (RENTON, 2005), these effects result from the altered 
expression of certain enzymes of the Cytochrome P450 fa-
mily (CYP 450) and of drug transport proteins, which are 
regulated downward (down regulation) during the generation 
of host defense mechanisms (MORGAN et al., 2008) . This 
has been demonstrated by different studies where significant 
modifications in the pharmacokinetics of drugs have been 
observed between animals treated LPS and control animals 
(GORALSKI et al., 2003; ELMAS et al., 2006; PÉREZ et 
al., 2015; PÉREZ et al., 2016).
CONCLUSIONS
Repeated dose administration of 1μg kg-1 LPS of 
Escherichia coli induced an APR in sheep and produced sig-
nificant changes in physiological variables, resulting in in-
creases in BT°, HR, RR and fever in treated animals. Also, 
the total and differential leukocyte counts decreased in the 
first 8 h of LPS injection, followed by leukocytosis.
The observed changes allow the characterization of 
the acute response to infection by Gram negative microorga-
nisms, mainly Escherichia coli.
We conclude that this is an animal model that gene-
rates minimal damages to the study subjects, which is easily 
reproducible, and that is useful to study the effects of APR 
on the physiological and immunological responses of the or-
ganism, and for potential future studies over the effects of 
infection on the pharmacokinetics of drugs used in veterinary 
medicine.
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